Medical Research News

RSS

Two different ways of remembering things initiated by entirely different signal paths in brain: Study

Entirely different signal paths and parts of the brain are involved when you try to remember something and when you just happen to remember something, prompted by a smell, a picture, or a word, for instance. This is shown by Kristiina Kompus in her dissertation at Umeå University in Sweden.

11 Mar 2010

BIDMC scientist presented with 2010 Arthur Steindler Award

Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, was presented with the 2010 Arthur Steindler Award at this week's annual meeting of the Orthopaedic Research Society in New Orleans.

11 Mar 2010

Study shows smokers have lower risk of developing Parkinson's disease

Researchers have new insight into the relationship between Parkinson's disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson's disease. A new study published in the March 10, 2010, online issue of Neurology ®, the medical journal of the American Academy of Neurology, shows that smoking for a greater number of years may reduce the risk of the disease, but smoking a larger number of cigarettes per day may not reduce the risk.

11 Mar 2010

Clinical research trial of new treatment to restore brain cells damaged by stroke passes safety stage

A clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage, according to the UC Irvine neurologist who led the effort.

11 Mar 2010

PBI and TDI announce strategic licensing and collaborative research and development agreement

Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.

11 Mar 2010

Small study shows eprotirome decreases LDL cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

10 Mar 2010

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

Accelr8 Technology Corporation today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis.

10 Mar 2010

Few CE studies compare medications with nonpharmacologic interventions, and examine safety or cost-effectiveness

An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.

10 Mar 2010

Reductions in tobacco use and increased screening for early detection reduces cancer death rates

A new American Cancer Society study finds progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The study appears in the open access journal PLos ONE, and finds a downturn in cancer death rates since 1990 results mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers.

10 Mar 2010

Children's Hospital Boston develops new web site, releases video message on current state of stem cell research

Exactly one year to the day after President Obama's historic decision to reverse an eight-year restriction on federally funded embryonic stem cell research, the Children's Hospital Boston Stem Cell Program today announced the development of a unique, comprehensive web site and released a candid video message from its top researchers on the current state of stem cell research to introduce the new site: stemcell.childrenshospital.org.

10 Mar 2010

Study provides first formal analysis of comparative effectiveness research on new therapies

An analysis by researchers at the Keck School of Medicine of the University of Southern California has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective.

10 Mar 2010

Health plan members who participate in health and fitness-related activities have lower healthcare costs

Employers are increasingly looking to workplace wellness programs to motivate employees to play an active role in improving their health, thereby reducing overall healthcare costs. Deepak N. Patel, MD, Mmed, senior clinical specialist for Discovery Vitality, will present new findings indicating that health plan members who participated in health and fitness-related activities within an incentive-based health insurance wellness program had significantly lower healthcare costs.

10 Mar 2010

Bayer's bioequivalence study comparing Adalat XL to Mylan-Nifedipine Extended Release flawed, says Mylan

Mylan today reported that it has identified multiple flaws within a purported bioequivalence study sponsored by Bayer Inc. of Canada. The study compared Bayer's antihypertensive Adalat(R) XL(R) tablets, 60 mg, marketed in Canada, to Mylan's approved generic version, Mylan-Nifedipine Extended Release tablets, 60 mg, marketed in Canada.

10 Mar 2010

African-Americans and Hispanics are at higher risk for developing Alzheimer's and dementias

According to the Alzheimer's Association's® 2010 Alzheimer's Disease Facts and Figures, African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer's and other dementias.

10 Mar 2010

Combating DVT and PE: Critical recommendations

Three critical recommendations from a national workshop have been released to address deep-vein thrombosis (DVT) and pulmonary embolism (PE), a growing public health problem estimated to affect nearly 1 million Americans each year.

10 Mar 2010

Young women with heart attacks at higher risk of dying in hospital than men

Geisinger Health System and Yale School of Medicine investigators are researching how young people recover from heart attacks through VIRGO (Variation in Recovery: Role of Gender on Outcomes in Young AMI Patients), a research project funded by the National, Heart, Lung and Blood Institute.

10 Mar 2010

Cellzome, GSK form second major alliance to develop new anti-inflammatory drugs

Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere(TM) technology in the emerging field of epigenetics as applied to immunoinflammatory disease. Epigenetic mechanisms play a key role in controlling immune cell differentiation and inflammatory gene expression during an excessive inflammatory response.

10 Mar 2010

Alison Walker selected to receive ASH-AMFDP Award

Alison Walker, MD, has been selected to receive the ASH-AMFDP Award, and will begin her research in acute myeloid leukemia in July of this year. The award, designed to help increase the number of underrepresented minority scholars in the field of hematology, is the result of a partnership between the American Society of Hematology and the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation.

10 Mar 2010

Childhood bad behaviour linked to chronic widespread pain in adult life

Bad behaviour in childhood is associated with long-term, chronic widespread pain in adult life, according to the findings of a study following nearly 20,000 people from birth in 1958 to the present day.

10 Mar 2010

2010 Max Planck Research Award for Dr. Timothy Bromage from NYU College of Dentistry

New York University College of Dentistry's Dr. Timothy Bromage has been selected to receive the 2010 Max Planck Research Award. Dr. Bromage will collaborate with Dr. Friedemann Schrenk of Frankfurt's Senckenberg Research Institute to research the microanatomical structure of bones and teeth, and the links between metabolic states, growth rates, life spans, and biological features such as sex and body size.

10 Mar 2010

Medical Research News

Two different ways of remembering things initiated by entirely different signal paths in brain: Study

BIDMC scientist presented with 2010 Arthur Steindler Award

Study shows smokers have lower risk of developing Parkinson's disease

Clinical research trial of new treatment to restore brain cells damaged by stroke passes safety stage

PBI and TDI announce strategic licensing and collaborative research and development agreement

Small study shows eprotirome decreases LDL cholesterol

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

Few CE studies compare medications with nonpharmacologic interventions, and examine safety or cost-effectiveness

Reductions in tobacco use and increased screening for early detection reduces cancer death rates

Children's Hospital Boston develops new web site, releases video message on current state of stem cell research

Study provides first formal analysis of comparative effectiveness research on new therapies

Health plan members who participate in health and fitness-related activities have lower healthcare costs

Bayer's bioequivalence study comparing Adalat XL to Mylan-Nifedipine Extended Release flawed, says Mylan

African-Americans and Hispanics are at higher risk for developing Alzheimer's and dementias

Combating DVT and PE: Critical recommendations

Young women with heart attacks at higher risk of dying in hospital than men

Cellzome, GSK form second major alliance to develop new anti-inflammatory drugs

Alison Walker selected to receive ASH-AMFDP Award

Childhood bad behaviour linked to chronic widespread pain in adult life

2010 Max Planck Research Award for Dr. Timothy Bromage from NYU College of Dentistry

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News